|Articles|August 20, 2007

New Guidelines Address Treatment of H. Pylori

ANN ARBOR, Mich. -- The American Journal of Gastroenterology has published medical guidelines for the treatment of Helicobacter pylori (H. pylori) infection, one of the most common worldwide infections and an important factor linked to the development of peptic ulcer disease, gastric malignancy and dyspeptic symptoms.

According to guideline author William D. Chey of the University of Michigan Medical Center, this document provides an evidence-based update on the management of H. pylori infection. "It has been estimated that 30 percent to 40 percent of the U.S. population is infected with H. pylori, and a significant amount of new information regarding the management of this infection has become available since the last guidelines were published in 1998, so the time was right to revisit the topic."

Topics covered within the guidelines include:

-- The accepted and controversial indications for testing and treating H. pylori infection

-- The best methods to test for H. pylori and how these diagnostic tests can most effectively be utilized in clinical practice

-- The latest and most effective treatments for H. pylori infection.

The study was published in the August issue of the American Journal of Gastroenterology.

Source: Blackwell Publishing Ltd.


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERISS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.